SecBot SecBot
144 ·Filed Nov 12, 2026

HAE

HAEMONETICS CORP
NEUTRAL
Impact 2/10
Horizonimmediate Processed4d 14h ago SEC0001959173-26-007949
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The filing is a routine Form 144 notice for a small share sale by an officer. No material impact on the stock is expected. Monitor for any subsequent Form 4 filings to confirm the sale was executed.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$122.71
T+0 close · Nov 12, 2026 · via day close
Latest settled
+0.19%
T+1 · $122.94
Vs SPY
+0.55%
α at T+1
Next horizon
T+5
in 2d
  1. T+0 · Nov 12 $122.71entry
  2. T+1 · 4d ago +0.19%α +0.55% · $122.94
  3. T+2 · todayOpen
  4. T+5 · in 2d Pending
  5. T+20 · in 24d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Maryanne Maunsell Farris, an officer of Haemonetics, filed a Form 144 notice of intent to sell 836 shares of common stock, with an estimated aggregate market value of approximately $101,144. The shares were acquired through restricted stock vesting and a stock option exercise. The sale is small relative to the company's $5.6B market cap and appears to be a routine insider transaction to cover tax obligations or diversify holdings.

Key Facts

  • Officer Maryanne Maunsell Farris intends to sell 836 shares of Haemonetics common stock.
  • Estimated aggregate market value of the sale is $101,144.38.
  • Shares were acquired through restricted stock vesting on 05/15/2024, 05/15/2025, and 05/17/2025, and a stock option exercise on 11/11/2026.
  • The sale is planned for on or after 11/12/2026 on the NYSE.
  • The filing represents less than 0.002% of Haemonetics' outstanding shares based on the $5.6B market cap.

Financial Impact

Sale of 836 shares valued at ~$101,144, representing a negligible fraction of the company's $5.6B market cap.

dilution

Risk Factors

  • Form 144 is an intent to sell; the actual sale may not occur.
  • The filing does not disclose the officer's total holdings, so the proportional impact on her position is unknown.

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
80% bullish (15 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-007949
Document: 0001959173-26-007949-index.html0001959173-26-007949
Document: 0001959173-26-007949.txt0001959173-26-007949

Track record

14 reports on HAE

Performance horizon

2 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +2.44% at T+5 after the Oct 20, 2026 report. 2 of 4 went positive at some point.

Filters
  1. Nov 12, 20264d ago 144 Neutral 2/10 Viewing Entry $122.71 Now $121.34 −1.12% settles Nov 19
  2. Nov 5, 202611d ago 8-K Bullish 6/10 No price data
  3. Nov 5, 202611d ago Press Release Bullish 5/10 Entry $124.11 to $122.71 Now $121.34 −2.23% ▼ −1.13% −4.42% vs SPY
  4. Oct 20, 202627d ago Institutional Cluster Bullish 4/10 Entry $117.11 to $119.97 Now $121.34 +3.61% ▲ +2.44% +2.89% vs SPY
  5. Oct 19, 202628d ago Press Release Bullish 7/10 Entry $118.21 to $119.97 Now $121.34 +2.65% ▲ +1.49% +1.41% vs SPY
  6. Oct 12, 20265w ago Institutional Cluster Bullish 4/10 Entry $122.06 to $118.73 Now $121.34 −0.59% ▼ −2.73% −1.23% vs SPY
  7. Oct 8, 20265w ago 8-K Neutral 4/10 Entry $119.47 to $121.29 Now $121.34 +1.57% ▲ +1.52% +1.80% vs SPY
  8. Sep 30, 20266w ago Press Release Neutral 1/10 Entry $104.37 to $119.47 Now $121.34 +16.26% ▲ +14.47% +13.17% vs SPY
  9. Sep 30, 20266w ago Court Ruling Neutral 3/10 Entry $104.37 to $119.47 Now $121.34 +16.26% ▲ +14.47% +13.17% vs SPY
  10. Aug 18, 202612w ago 8-K Neutral 3/10 Entry $104.65 to $108.32 Now $121.34 +15.95% ▲ +3.51% +3.71% vs SPY
Showing 10 of 14

US Market Status

Market Closed · Opens Wed (11h 5m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026